New eye drop could ease pain of Sight-Saving shots

NCT ID NCT05747430

Completed Symptom relief Sponsor: iRenix Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Apr 14, 2026 · Last updated Jun 08, 2026 · Updated 9 times

Summary

This study tested a new drug called IRX-101 to see if it reduces pain and damage to the eye's surface after common sight-saving injections. 155 adults with retinal disease received either IRX-101 or a standard cleaning solution before their injection. The goal was to make the procedure more comfortable and protect the eye.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Charleston Neuroscience Institute

Ladson, South Carolina, 29456, United States
Coastal Eye Surgeons, LLC

Greenwich, Connecticut, 06830, United States
Edward Wood, MD

Round Rock, Texas, 78681, United States
Erie Retina Research, LLC

Erie, Pennsylvania, 16507, United States
Mississippi Retina Associates

Madison, Mississippi, 39110, United States
Retina Associates of Utah

Salt Lake City, Utah, 84107, United States
Retina Consultants of Texas

Katy, Texas, 77494, United States

Conditions

Explore the condition pages connected to this study.

RETINAL DISEASE